{"name":"XBiotech, Inc.","slug":"xbiotech-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Hutrukin","genericName":"Hutrukin","slug":"hutrukin","indication":"Other","status":"phase_1"},{"name":"Natrunix","genericName":"Natrunix","slug":"natrunix","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Hutrukin","genericName":"Hutrukin","slug":"hutrukin","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Natrunix","genericName":"Natrunix","slug":"natrunix","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPQ3hucWhOMEtKcGJKRUQ0OUNpNnppRGRqbzRnSW9ldExMVFktWWFZNWViQ1hhZk1ZTHFLRjdNck0xUUlfcEJHOV9nT1JsamNVNXlSd2pHblJQSTV0UDhlNWg1emM5dnNUOUdOa0RibUhIbF8yWnhYLVFlY0Z4Y0FHbEtmUzNOdGdMc0xoUGFHUTEtVWtVajdXR09kRDFWSFNJcTJRWGxST19UTnpkYmFBMjBLaXVLbGhM?oc=5","date":"2026-03-26","type":"pipeline","source":"AD HOC NEWS","summary":"XBiotech Inc stock faces biotech sector headwinds amid pipeline uncertainty and market volatility - AD HOC NEWS","headline":"XBiotech Inc stock faces biotech sector headwinds amid pipeline uncertainty and market volatility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9QbngyLV9aMS05TG9UcWFVTk9mVE9pdUwwZVpyQlFpNUNhRXRZMjd3dkZFRnBOLWVNcGV4bjVUQ3duZkNkcG9LdDIxRnNPWlpMWElsc1VreW11SWZ0TzZLc21vLU1oenNfRWxXcDd3?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Xbiotech (XBIT) - Stock Titan","headline":"If You Invested $1,000 in Xbiotech (XBIT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOWnU3YnJCYzNuV0Y1RUFWQXpUYlFDTXhGa1hlMnhGRjAyRy01WXNJc05KSmd3RUVKZmV0aUxXWjVPbkV2dkhwb0s1NFdOWTRKSUVvYW8zdFNGSGJQSG5NMzFVQnB3WC12dS1ZQ3VPQnJ0a3pkVzdfTUlaMmV1bEp4VVJ1YS1QTmRBYlpJOGNYQ0c0M3VFcmZyeVhLTnJQcENYcmdkTHNWSmZiam45YlBwRVI0eHhJNkJPX0ZjdE1mZ2hOX0c5dVRNeUZtOU1LUzNpQjJhZ2NwNmpTQlBoSlh0VmpxbDBaWkZQX05YVmlvMFRzZXc2bnBRd2RrS3hNZFphTVhkT2hCc3BMUlliNHd3bXl3ZnJXa3M5NEFqR1ZNdHlERG_SAaMCQVVfeXFMTlp1N2JyQmMzbldGNUVBVkF6VGJRQ014RmtYZTJ4RkYwMkctNVlzSXNOSkpnd0VFSmZldGlMV1o1T25FdnZIcG9LNTRXTlk0SklFb2FvM3RTRkhiUEhuTTMxVUJwd1gtdnUtWUN1T0JydGt6ZFc3X01JWjJldWxKeFVSdWEtUE5kQWJaSThjWENHNDN1RXJmcnlYS05yUHBDWHJnZExzVkpmYmpuOWJQcEVSNHh4STZCT19GY3RNZmdoTl9HOXVUTXlGbTlNS1MzaUIyYWdjcDZqU0JQaEpYdFZqcWwwWlpGUF9OWFZpbzBUc2V3Nm5wUXdka0t4TWRaYU1YZE9oQnNwTFJZYjR3d215d2ZyV2tzOTRBakdWTXR5RERv?oc=5","date":"2026-02-04","type":"trial","source":"Bolsamania","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Bolsamania","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNbms5R1NlWUlPRDJVbGdUaG1YdXVPSloydmQ2UDRFM3RYandhbV95R3pnWFF5Y2cwQ3hvRmV5OUxWYW5vSzV5bVZnbWxnR2F2a0VBNkFDb3Ywa2c4b3ZJZFlnZ3gyWUdjNU81aVFaQndKbGlFS1pYZG55ZFNodFlBTXZHaTNWaHk0WFZyT0ZCNzZLbXdrc1JyZFdiRUN5N2d6S0E2cHY5cDhkNzZHN0I3UjN3djJld3ZtaGtCMVpqREg2RGExS0kxT0tiazVRMXfSAdQBQVVfeXFMUHVLQk0wVUxVNjZlR0tXRXJYcGhuV1hhcVJhcTF2bWFpeXI2YWxibEtVaE1lc0JLbmNEVk5wYjB2VXR0MEktVW5kN2R5VWpaR0JKTDNNbU5NUnVEU1RPRmY1TlJEMVNzemR6RW40cW9lNEthSDBlbFRpa25ZZGlBcHRUcUlIT1I4dnZuZjZ4SEN0MU9LOTdfblVfbERxNmlNY0J1Sm92Skt2cjNSX1JuZGJmT3BPNENpN3hDMlR0Q2Q3cWltbk1kMHlETzgzXzZvanczVU8?oc=5","date":"2025-12-19","type":"pipeline","source":"simplywall.st","summary":"3 Promising Penny Stocks With Market Caps Over $30M - simplywall.st","headline":"3 Promising Penny Stocks With Market Caps Over $30M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPajJuUm5QNldIcXV5VXpKTkRFSzM1dFZlUXdnaGRwSEU4UENPN0hhT3lTTjAzNGJMMkwzUGF6QS1OblhGOERGWDlEbU9jSlVaRlRjTC1DVVE0M1lCQkxkNHJ4Y2hlZGhiUnBzYjU2QjN0NTZaSmsxREFiVS1TVkZNZkp3VmM3TEhYYXNXUkhDV0RqWG9zbldYSmdodmg1V3JQZlNWeW9mWlRDX1FrUDBpOExEdnlWQQ?oc=5","date":"2024-12-24","type":"trial","source":"Clinical Trials Arena","summary":"XBiotech halts all rheumatology research after missing Phase II endpoints - Clinical Trials Arena","headline":"XBiotech halts all rheumatology research after missing Phase II endpoints","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNSlZySGt2VHJsVDExb1JHZ0tMWVFDb3NwSjQ5Mm1vc1ZJLXJOV3FHSnBueXJ5MGdXRWJoclM4QzR3Znk5bUp3MzJ5M3NxNzlkNUQxZ0tqZGdidWVfbHdsUGNuSlc1MlV6YkQyUHhYOWM2R3VEMFVHcmdLQS1oYTY1RUxaRmxSeGpjX2JYZ2Y2bkFwMnZERnlkUDItSmJCcUpTU0s0V2J6RQ?oc=5","date":"2024-05-24","type":"pipeline","source":"seekingalpha.com","summary":"XBiotech: Several Shots On Goal In Big Target Market Indications (NASDAQ:XBIT) - seekingalpha.com","headline":"XBiotech: Several Shots On Goal In Big Target Market Indications (NASDAQ:XBIT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPdFlFdnc0MDlPX0NURHZRQ0puSkV0ck14MEM2dGtyaHJBajA4U09zZkZhV21WSU1zNU9qTWhsdUFvSzlZM2tYaDZqY0NFZDhLTm5taUs2TGY1bkVpcllESDl1OGdRWFZhNDVoUFF6X0lJdGZqdW5HQVFZWFVoR3ZPVDFNQjJ6anY1dmRQSVNuWk5mTk1YaUZnM1N2WUxROVFuQk9FQzJCTnBEdXM?oc=5","date":"2022-02-02","type":"pipeline","source":"Reuters","summary":"J&J to record $610 mln charge related to skin disease drug - Reuters","headline":"J&J to record $610 mln charge related to skin disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQSHN2SGY5WXg0QXQ4MUEyODJZOW1VaWpiRlFaSEZ3MERZSVBSWnE1U2paT0taa1hrb1R6ZjRWdGgzQUJDay1iVTdCakU0NDFudi1fQXFFTnMxLWxtTmIxVmxBV3U4NUVpUUZzOEhmOWM0MnExRUVjdHBLalNncHc5bkdrRjZHekQyQXB3WmFiRm5ZQ20teU1tUGxkdWVHRlVOalhDMjhB?oc=5","date":"2020-02-10","type":"deal","source":"The Business Journals","summary":"$1.35B deal offers vindication, runway for Austin-based XBiotech - The Business Journals","headline":"$1.35B deal offers vindication, runway for Austin-based XBiotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPblRDanZsZ1FzanF1RmM3djdaV3phdzFLOFQ0anRjRkliUmVfWFg1SXdUMl9CMzJTWEZLazNISDBqLUxXQ2R0SXNCZktfNWZkVnA3RDQ1WGViOTlJN0txM3lKV1B0bEkzdEM0d2NuVzFOYTRINlpuZjVQTG5Cak5KQnM3RWllbVNWVVJ5VF84R3hZV0EwZ3dHUVlQNHBXcTFvNHFCeXJNekFDSER4cDZUcG5PbVZENG5LQ3pacnBRWjRSRFFGUGRKTnJwdVQzRmhkczlMaGFILUxYeFhNVFpnZQ?oc=5","date":"2019-12-30","type":"pipeline","source":"prnewswire.com","summary":"Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc. - prnewswire.com","headline":"Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1sQjJSRlJsTXQza2E5ZTQ2TEk3Vm9TVnBuTENTUTZXNWNISFlfWjJYNDM1d19pR2RXTE5KWFZxUzExME9ZQXMtVTBnUGtkellJM0FUX3ZfWXVVVWQ0aDNjTGFxNHN6bHgxbzMyVEF0SHpGdmdWUzdCRURDdFBWdw?oc=5","date":"2019-12-09","type":"pipeline","source":"Fortune","summary":"Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology - Fortune","headline":"Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQbnJZM3pMelp6endYNzFpMDl0RnVvTDRZQmVwQTZyMkZIeTVQMWRac2ptUzc1ZHRnTlFDYjV4OHBhUS1WTXpzZ2ZNSW5aZW5ydDNueUNrYnZORjdRa2NLXzNfbDg2bG43Vk80SFB0ZUdzODc0NkpHaVRyWnJDVDVzTFUtb1pkcWFPQ1ZYRHBnM1huVmhoN3RVVXVpblE4RTNubUhwLVctTTZxa1FBaHc0SjJYa2lNdw?oc=5","date":"2019-12-07","type":"deal","source":"prnewswire.com","summary":"Janssen to Acquire Investigational Bermekimab from XBiotech - prnewswire.com","headline":"Janssen to Acquire Investigational Bermekimab from XBiotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQejN6Nk90bEJoN3E1bDBfSjZGVnBmZFpneGZLVmVIaVBfM3NfaHp4Q2hqZk9BZTJRR3VuMm85RWMxM0Y4MlZoaDYxNHByeDE3aHJ3d1htMTVhaVltOVVVTjNhelFBZ3NnMVNlRzAwMnV1eDJUNlZvZzBkanNOVzN5TVpSYkRNRkV6YmxpaG43a1dBNGdubUthTkxJckJaZHNrWTVza3dBMF9Udw?oc=5","date":"2016-09-24","type":"pipeline","source":"Austin American-Statesman","summary":"XBiotech prices Austin’s first IPO of 2015 - Austin American-Statesman","headline":"XBiotech prices Austin’s first IPO of 2015 - Austin American","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_2":1},"enrichmentLevel":0,"visitCount":8,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}